Product

X-PACT

1 clinical trial

1 indication

Indication

Advanced Solid Tumor Cancer

Clinical trial

Phase 1 Study of X-PACT (X-ray Psoralen Activated Cancer Therapy) for Intra-tumoral Injection of Superficial Tumors in Patients With Advanced Head and Neck Cancer, Breast Cancer, Soft Tissue Sarcoma or Melanoma

Status: Recruiting, Estimated PCD: 2024-09-01